Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Plant cell elongation pathway" is not a single molecule, protein, or gene, but a complex biological process regulated by multiple molecular components, signals, and pathways rather than a discrete protein target or receptor. It is not considered a canonical drug target, but rather refers to the signaling and molecular machinery governing plant cell elongation. The plant cell elongation pathway encompasses a network of hormones (notably auxin, brassinosteroids, gibberellins, and abscisic acid) and molecular components that drive the expansion of plant cells, especially within growing tissues such as roots, shoots, and stems[1][2][3][4][5][7][8][9]. At the cellular level, this process requires loosening and restructuring of the cell wall to permit water uptake and turgor-driven stretching. The pathway integrates input from the environment (e.g., light, temperature) with endogenous signals: - Auxin triggers cell wall loosening by promoting apoplastic acidification, activating wall-modifying enzymes like expansins, polygalacturonases, and pectin methylesterases[1][5][7]. - Brassinosteroids signal through specific receptor-like kinases such as BRI1; additional kinases like HERKULES1, THESEUS1, and FERONIA modulate cell elongation partially independently of BRs[2]. - Gibberellins promote elongation by relieving repression from DELLA proteins, allowing auxin-regulated transcription factors (e.g., ARF6) and others (e.g., PIF4, BZR1) to activate growth gene networks[5]. - Transcription factors and regulators, including a triantagonistic basic helix-loop-helix (bHLH) network (e.g., PRE1, IBH1, ACEs), coordinate transcription of genes governing growth, modulated by hormone signaling[4][5]. - Transporters (e.g., PINs for auxin transport, PILS for intracellular auxin sequestration) are essential for local hormone gradients and responsiveness[7]. This pathway enables plants to adapt growth direction and rate in response to developmental cues and environmental changes. It is not a single therapeutic target but a system of interacting biochemical components fundamental to plant biology. Limitations: There is no single receptor or protein named "Plant cell elongation pathway"; reference to it as a drug target is incorrect. Specific therapeutic targeting in this pathway would require focusing on an individual molecule (such as the auxin receptor TIR1, the brassinosteroid receptor BRI1, or transcription factors like ARF6 or BZR1)[5][8]. If a precise component is needed, further clarification or narrowing of the query is required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plant cell elongation pathway (null).